Details of the Drug Reposition

General Information of This Drug (ID: DMDVP3B)

Drug Name
Pregabalin   DMDVP3B
Synonyms Pregabalin CR; Pregabalin (controlled-release, oral); Pregabalin (controlled-release, oral), Pfizer
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Vulvodynia DISBL7S1 N.A. Approved [1]
Postherpetic neuralgia DISCQ39I 1E91.5 Approved [1]
Epilepsy DISBB28L 8A60-8A68 Approved [1]
Pain DIS4RWOW MG30-MG3Z Approved [1]
------------------------------------------------------------------------------------
1 Withdrawn Indication(s)
Indication Name Indication ID ICD-11 Status REF
Fibromyalgia DISZJDS2 MG30.01 Withdrawn [2]
------------------------------------------------------------------------------------
2 Discontinued in Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Spinal injury DISO0NRV N.A. Discontinued in Phase 3 [3]
Generalized anxiety disorder DISPSQCW 6B00 Discontinued in Phase 3 [4]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Chronic obstructive pulmonary disease DISQCIRF CA22 Discontinued in Phase 2 [5]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Neuralgia DISWO58J N.A. Investigative [1]
------------------------------------------------------------------------------------

References

1 Pregabalin FDA Label
2 Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICS
3 Modafinil in Opioid Induced Sedation
4 Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer
5 S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium